Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1863024rdf:typepubmed:Citationlld:pubmed
pubmed-article:1863024lifeskim:mentionsumls-concept:C0009324lld:lifeskim
pubmed-article:1863024lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:1863024lifeskim:mentionsumls-concept:C0127615lld:lifeskim
pubmed-article:1863024lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:1863024lifeskim:mentionsumls-concept:C0547040lld:lifeskim
pubmed-article:1863024lifeskim:mentionsumls-concept:C1881878lld:lifeskim
pubmed-article:1863024lifeskim:mentionsumls-concept:C1096776lld:lifeskim
pubmed-article:1863024lifeskim:mentionsumls-concept:C0678172lld:lifeskim
pubmed-article:1863024pubmed:issue5lld:pubmed
pubmed-article:1863024pubmed:dateCreated1991-8-30lld:pubmed
pubmed-article:1863024pubmed:abstractTextTo evaluate the efficacy and safety of a pH-sensitive, polymer-coated oral preparation of mesalamine in patients with mildly to moderately active ulcerative colitis.lld:pubmed
pubmed-article:1863024pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1863024pubmed:languageenglld:pubmed
pubmed-article:1863024pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1863024pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1863024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1863024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1863024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1863024pubmed:statusMEDLINElld:pubmed
pubmed-article:1863024pubmed:monthSeplld:pubmed
pubmed-article:1863024pubmed:issn0003-4819lld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:CerdaJ JJJlld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:ShanahanFFlld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:TarganS RSRlld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:CortD HDHlld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:JacobsW HWHlld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:SessionsJ TJTlld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:ONOMMlld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:SninskyC ACAlld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:PowersB JBJlld:pubmed
pubmed-article:1863024pubmed:authorpubmed-author:PruittR ERElld:pubmed
pubmed-article:1863024pubmed:issnTypePrintlld:pubmed
pubmed-article:1863024pubmed:day1lld:pubmed
pubmed-article:1863024pubmed:volume115lld:pubmed
pubmed-article:1863024pubmed:ownerNLMlld:pubmed
pubmed-article:1863024pubmed:authorsCompleteNlld:pubmed
pubmed-article:1863024pubmed:pagination350-5lld:pubmed
pubmed-article:1863024pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:meshHeadingpubmed-meshheading:1863024-...lld:pubmed
pubmed-article:1863024pubmed:year1991lld:pubmed
pubmed-article:1863024pubmed:articleTitleOral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study.lld:pubmed
pubmed-article:1863024pubmed:affiliationVeteran Affairs Medical Center, Gainesville, Florida.lld:pubmed
pubmed-article:1863024pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1863024pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1863024pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:1863024pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:1863024pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1863024lld:pubmed